{
    "nct_id": "NCT02958865",
    "official_title": "A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS",
    "inclusion_criteria": "* Diagnosis of ulcerative colitis for greater than/equal to 3 months.\n* Moderate to severe active ulcerative colitis\n* Inadequate response to, loss of response to, or intolerance to at least one conventional therapy for UC.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* Pregnant or breastfeeding\n* Clinical findings suggestive of Crohn's Disease\n* History of bowel surgery within 6 months",
    "miscellaneous_criteria": ""
}